Health
Argonne’s Advanced Photon Source guided the development of new COVID-19 vaccine now in trials – News-Medical.net
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two…
Human clinical trials have begun on a new vaccine candidate that may protect against not only SARS-CoV-2, the virus that causes COVID-19, but against at least two of the variants emerging around the world. The development of this new vaccine was guided by structural information on the virus obtained at the Advanced Photon Source (APS), a U.S. Department of Energy (DOE) Office of Science User Facility at DOE’s Argonne National Laboratory, and other light sources.
Trials are taking place at the Walter…
-
Noosa News18 hours agoBidding for a good cause
-
General21 hours agoRyan Routh to face court charged with attempted assassination of Donald Trump
-
Noosa News17 hours agoData shows 73 serving and former Australian Defence Force members died by suicide in 2023
-
Noosa News17 hours agoAustralian-funded PALM scheme liaison workers say they went months without pay